MSP Recovery Enters Into Agreement With Prudent Group To Monetize Up to $250 Million in Certain Property & Casualty Claim Recoveries on a Non-Recourse Basis
MSP Recovery (NASDAQ: MSPR) announced an agreement with Prudent Group to monetize up to $250 million in its Net Recovery Proceeds. This strategic relationship aims to enhance access for European investors in the U.S. healthcare industry. MSPR has been sending individual claim demand letters to insurers, which led to a rise in payments received. The deal enables Prudent Group to acquire a percentage of MSPR's recovery rights on a non-recourse basis, specifically targeting individual demand letters.
- MSPR enters a strategic agreement with Prudent Group to monetize recovery proceeds up to $250 million.
- The agreement allows access to investments in the U.S. healthcare sector for European investors.
- MSPR's efforts in sending demand letters have increased payments from responsible parties.
- None.
Insights
Analyzing...
Agreement Relates to Previously Announced Individual Claim Demand Letters Being Sent by MSPR to Property and Casualty Insurers
CORAL GABLES, Fla., July 04, 2022 (GLOBE NEWSWIRE) -- MSP Recovery, Inc. (NASDAQ: MSPR) (“MSPR” or the “Company”) today announced that the Company has entered into an agreement to monetize up to
“This agreement is part of a more strategic relationship to provide an attractive access point to invest in the U.S. healthcare industry for our European investors,” says Dennis Klemming, Founder of The Prudent Group, a global alternative asset management firm pursuing diverse and unique opportunity sets across different industry sectors, asset classes, and geographies, including acquiring receivables from healthcare entities.
As previously announced on June 13, 2022, MSPR has commenced sending individual claim demand letters to insurers who admitted they had primary payer responsibility for the underlying accidents to the federal government. As a result of these efforts, MSPR has experienced an increase in the volume of payments received from such responsible parties. The agreement with Prudent Group relates specifically to these demand letters and gives MSPR the right to direct, at MSPR’s discretion, the Prudent Group to acquire a percentage of MSPR’s recovery rights in the individual claim demand letters on a non-recourse basis – up to an aggregate total of
How it works?
MSPR acquires the assignments of its recoveries from health insurance payors, healthcare providers and self-funded entities, and uses its proprietary multi-level data analytics system to secure recoveries from responsible parties. MSPR typically pays the assignors
Pursuant to the agreement with Prudent Group, at MSPR’s sole and absolute discretion, Prudent Group will acquire, on a non-recourse basis, MSPR’s Net Recovery Interest relating to the individual claim demand letters. Specifically, Prudent Group has committed to acquire up to
In conjunction with the agreement, MSPR will service and recover on the demand letters and will retain any revenues generated in excess of the amount received from Prudent Group, plus up to an
By way of example, if the paid amount of a claim set forth in the demand letters is
“In addition to the long-term investment relationship with Virage Capital Management, this agreement with Prudent Group is one of many examples of the real value of MSPR’s assets and illustrates the many ways in which those assets can be monetized on a non-recourse basis,” said MSPR Founder and CEO, John H. Ruiz. “More than
About MSP Recovery
Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions, while innovating technologies to help save lives. For more information, visit: www.msprecovery.com
Forward Looking Statement
This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSPR in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for MSPR to predict or identify all such events or how they may affect it. MSPR has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, MSPR’s ability to capitalize on its assignment agreements and recover monies that were paid by the assignors; litigation results; the validity of the assignments of claims to MSPR; the ability to successfully expand the scope of MSPR’s claims or obtain new data and claims from MSPR’s existing assignor base or otherwise; MSPR’s ability to innovate and develop new solutions, and whether those solutions will be adopted by MSPR’s existing and potential assignors; negative publicity concerning healthcare data analytics and payment accuracy; and those other factors included in MSPR’s Annual reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.
